New implant lets heart patients check pressure from home
NCT ID NCT04012944
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a small sensor implanted in the lung artery that sends daily pressure readings to doctors. It involves 81 adults with advanced heart failure (NYHA Class III). The goal is to see if the device is safe and accurate, helping patients avoid hospital stays by catching problems early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cordella Pulmonary Artery Sensor System (implantable device)
- What this could lead to
- If successful, this device could help heart failure patients manage their condition at home by tracking lung artery pressure daily, potentially reducing hospital visits.
- What could go wrong
- This is an early-stage trial with only 81 participants, so results may not apply to all patients. Risks include device-related complications or inaccurate readings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS III are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardivascular Center OLV Aalst
Aalst, Belgium
-
Klinik für Kardiologie und Angiologie/ Studienambulanz Medizinische Hochschule Hannover (MHH)
Hanover, Germany
-
Mater Misericordiae University Hospital
Dublin, Ireland
-
Uniklinik Köln, Klinik III für Innere Medizin Herzzentrum der Universität zu Köln
Cologne, Germany
-
University Hospital Galway
Dublin, Ireland
-
Universitätsklinikum Giessen und Marburg GmbH, Standort Giessen Medizinische Klinik I, Abteilung Kardiologie und Angiologie
Giessen, Germany
-
Ziekenhuis- Oost Limburg
Genk, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple chair test may predict heart failure prognosis
- Tiny Lung-Artery sensor could help heart failure patients live longer
- Pacemaker tweak may ease heart failure by calming nerves
- Tiny lung sensor could keep heart failure patients out of the hospital
- Heart MRI breakthrough: new scan could replace needle biopsy for rare heart disease
- Can a phone call a week help heart patients live better?